YorkBridge Wealth Partners’s Teva Pharmaceuticals TEVA Stock Holding History

YorkBridge Wealth Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-580	Closed	-$5K	–	591
2019 Q2	$5K	Hold	580	–	–	﹤0.01%	659
2019 Q1	$9K	Hold	580	–	–	﹤0.01%	611
2018 Q4	$9K	Hold	580	–	–	﹤0.01%	591
2018 Q3	$12K	Hold	580	–	–	0.01%	590
2018 Q2	$14K	Hold	580	–	–	0.01%	587
2018 Q1	$11K	Hold	580	–	–	0.01%	605
2017 Q4	$11K	Sell	580 -364	-39%	-$5.48K	0.01%	621
2017 Q3	$17K	Hold	944	–	–	0.01%	567
2017 Q2	$31K	Sell	944 -178	-16%	-$5.51K	0.02%	437
2017 Q1	$36K	Sell	1,122 -728	-39%	-$24.8K	0.02%	410
2016 Q4	$71K	Buy	+1,850	New	+$73.9K	0.04%	300

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

YorkBridge Wealth Partners's TEVA Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 580 shares — an estimated $5K sold.

YorkBridge Wealth Partners first reported a position in TEVA in Q4 2016 and held it in 11 quarters. The position peaked at $71K in Q4 2016. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

YorkBridge Wealth Partners reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
YorkBridge Wealth Partners sold 580 Teva Pharmaceuticals shares in Q3 2019, an estimated $5K.
YorkBridge Wealth Partners first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 11 quarters.
YorkBridge Wealth Partners's Teva Pharmaceuticals position peaked at $71K in Q4 2016.
427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.